Parkinson disease is one of the most common neurodegenerative disorders and is characterized by the selective loss of dopaminergic neurons in the substantia nigra. Although a decrease in proteasome activity has been found in patients with sporadic Parkinson disease, the relationship between the ubiquitin-proteasome system and dopaminergic neuronal death remains to be elucidated. Here, we review a mechanism in which proteasome inhibition provides dopaminergic neuroprotection from oxidative stress. Treatment with lactacystin, a proteasome inhibitor, significantly suppressed 6-hydroxydopamine (6-OHDA)-induced toxicity and oxidative stress in PC12 cells. In addition, lactacystin enhanced glutathione synthesis via elevation of γ-glutamylcysteine synthetase (γ-GCS) mRNA levels. Expression of antioxidant enzymes, such as γ-GCS and hemeoxygenase-1 (HO-1), is regulated by the nuclear factor-erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathway. Lactacystin induced Nrf2 accumulation and increased ARE activity. In mesencephalic cultures, lactacystin-induced upregulation of HO-1 in astrocytes contributed to dopaminergic neuroprotection against 6-OHDA-induced toxicity. These data suggest that proteasome inhibition provides cytoprotection against oxidative stress by activating the Nrf2-ARE pathway. Subsequently, we attempted to identify a novel Nrf2-ARE activator in dietary fruits and vegetables. Using bioactivity-guided fractionation, we identified 2′,3′-dihydroxy-4′,6′ -dimethoxychalcone (DDC) from green perilla leaves as the activator responsible for the increased activation of the ARE pathway. DDC upregulated γ-GCS and HO-1 and protected PC12 cells against 6-OHDA-induced toxicity. In conclusion, the activation of the Nrf2-ARE pathway may be an effective means to prevent dopaminergic neuronal death in patients with Parkinson disease.